tiprankstipranks
Humacyte prices 2.8M shares at $5.34 in registered direct offering
PremiumThe FlyHumacyte prices 2.8M shares at $5.34 in registered direct offering
8d ago
Humacyte Faces Financial Uncertainty: Potential Impact on Share Price and Capital
Premium
Company Announcements
Humacyte Faces Financial Uncertainty: Potential Impact on Share Price and Capital
13d ago
Humacyte Reports Q3 2024 Results Amid FDA Review
Premium
Company Announcements
Humacyte Reports Q3 2024 Results Amid FDA Review
14d ago
Hertz Global Holdings call volume above normal and directionally bullish
PremiumThe FlyHertz Global Holdings call volume above normal and directionally bullish
1M ago
Unusually active option classes on open October 18th
Premium
The Fly
Unusually active option classes on open October 18th
1M ago
Humacyte issues raised in 483 appear ‘fixable,’ says BTIG
Premium
The Fly
Humacyte issues raised in 483 appear ‘fixable,’ says BTIG
1M ago
Humacyte to sell 5.68M shares at $5.28 in registered direct offering
PremiumThe FlyHumacyte to sell 5.68M shares at $5.28 in registered direct offering
2M ago
Humacyte to participate in a conference call with Benchmark
Premium
The Fly
Humacyte to participate in a conference call with Benchmark
2M ago
Humacyte announces allowance of U.S. patent covering BioVascular Pancreas
Premium
The Fly
Humacyte announces allowance of U.S. patent covering BioVascular Pancreas
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100